FindTrial
Sign In

COMPARISON OF BENEFICIAL EFFECTS OF INTRAVENOUS IRON WITH ORAL IRON IN TREATING ANEMIA FOLLOWING CHILDBIRTH.

INTRAVENOUS IRON-SUCROSE COMPLEX VERSUS ORAL IRON IN THE TREATMENT OF POSTPARTUM ANEMIA.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/05/003624
Enrollment
100
Registered
2013-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- WOMEN WITH ANEMIA IN THE POSTNATAL PERIOD

Interventions

Intervention1: INTRAVENOUS IRON-SUCROSE INJECTION: STUDY GROUP will receive200mg of iron sucrose in 100ml of normal saline and to be infused over 1 hour every alternate days till the total calculated

Sponsors

NRS MEDICAL COLLEGEKOLKATA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Postpartum women irrespective of mode of delivery who are hemodynamically stable with moderate IDA(Hb 6-8gm/dl)and serum ferritin <15 microgram/l at 24-48 hours of delivery will constitute the study population.

Exclusion criteria

Exclusion criteria: Thalassaemic trait, peripartum blood trasfusion,active postpartum hemorrhage, allergy or intolerence to iron preparation previously, evidence of sepsis , hepatic, cardiovascular ,renal ,thrmoembolic disorder .

Design outcomes

Primary

MeasureTime frame
Haemoglobin , haematocrit , red cell indices,serum ferritinTimepoint: 0,7,14,40 days.—

Secondary

MeasureTime frame
side effects and complicationsTimepoint: 0,7,14,40 days.—

Countries

India

Contacts

Public ContactDR PICKLU CHAUDHURI

N.R.S MEDICAL COLLEGE,KOLKATA

picklu.chaudhuri@gmail.com9432277443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026